Stiefel Labs’ Psoriasis/Eczema Foam OK’D

Stiefel Laboratories said Tuesday it has been approved for U.S. sales of Olux-E Foam 0.05 percent to treat psoriasis and eczema.

The approval covers patients 12 years of age and older, the company said.

Stiefel said the foam would be available in U.S. pharmacies by March in 50 gram and 100 gram canisters.

My patients found Olux-E was easier to apply, disappeared more quickly into the skin, and did not have the sticky feel of an ointment or cream, said Joel Schlessinger, director of the Advanced Skin Research Center in Omaha, Nebraska, and president of the American Society of Cosmetic Dermatology and Aesthetic Surgery, in a statement issued by the company. Foams just seem to be patient-preferred over gels, creams, ointments or solutions, said Schlessinger, who was one of the investigators in the Olux-E study.